Interferon γ-Primed Mesenchymal Stromal Cells as Prophylaxis for Acute Graft v Host Disease
Status:
Recruiting
Trial end date:
2023-08-01
Target enrollment:
Participant gender:
Summary
The protocol is a phase I open label study evaluating the safety and feasibility of
peri-transplant infusion of freshly expanded interferon gamma primed MSCs in adult and
pediatric patients undergoing HCT for acute leukemia and myelodysplastic syndrome (MDS).